Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease
NCT04805099
·
clinicaltrials.gov ↗
COMPLETED
Status
126
Enrollment
OTHER
Sponsor class
Conditions
Autoimmune Diseases
Checkpoint Inhibitor
Immunotherapy
Interventions
DRUG:
Checkpoint inhibitor
Sponsor
Hellenic Cooperative Oncology Group